<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04177641</url>
  </required_header>
  <id_info>
    <org_study_id>19/09/2018-15-3</org_study_id>
    <nct_id>NCT04177641</nct_id>
  </id_info>
  <brief_title>Evaluation of Thioldisulfide Balance in Cervical Preinvasive Lesions</brief_title>
  <official_title>Investigation of Thiol-disulfide Balance in Cervical Preinvasive Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Muğla Sıtkı Koçman University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Muğla Sıtkı Koçman University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate Thiol-disulfide balance in patients with cervical
      preinvasive lesions
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To date various oxidative stress paramaters were studied in patients with cervical
      preinvasive lesions, however dynamic thiol disulfide hemostasis has not been previously
      investigated. The thiol-disulfide balance in the circulation will be measured by the
      automated system created by Erel &amp; Neselioglu(1).

      References 1- Erel O, Neselioglu S. A novel and automated assay for thiol/ disulphide
      homeostasis. Clin Biochem 2014;47:326-32. doi:10.1016/ j.clinbiochem.2014.09.026.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 20, 2018</start_date>
  <completion_date type="Actual">January 10, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>serum native thiol level</measure>
    <time_frame>baseline (preoperative in the morning or preprandial for healthy volunteers)</time_frame>
    <description>serum native thiol level in μmol/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serum disulphide level</measure>
    <time_frame>baseline (preoperative in the morning or preprandial for healthy volunteers)</time_frame>
    <description>serum disulphide level in μmol/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serum total thiol level</measure>
    <time_frame>baseline (preoperative in the morning or preprandial for healthy volunteers)</time_frame>
    <description>serum total thiol level in μmol/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the disulphide/native thiol ratio</measure>
    <time_frame>baseline (preoperative in the morning or preprandial for healthy volunteers)</time_frame>
    <description>the disulphide/native thiol ratio X (100 )</description>
  </primary_outcome>
  <primary_outcome>
    <measure>disulphide/total thiol ratio</measure>
    <time_frame>baseline (preoperative in the morning or preprandial for healthy volunteers)</time_frame>
    <description>disulphide/total thiol ratio X (100 )</description>
  </primary_outcome>
  <primary_outcome>
    <measure>native thiol/total thiol ratio</measure>
    <time_frame>baseline (preoperative in the morning or preprandial for healthy volunteers)</time_frame>
    <description>native thiol/total thiol ratio X (100 )</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>total antioxidant capacity (TAC)</measure>
    <time_frame>baseline (preoperative in the morning or preprandial for healthy volunteers)</time_frame>
    <description>TAC in mmol trolox equivalent/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total oxidant capacity (TOC)</measure>
    <time_frame>baseline (preoperative in the morning or preprandial for healthy volunteers)</time_frame>
    <description>TOC in mmol H2O2 equivalent/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress index (OSI)</measure>
    <time_frame>baseline (preoperative in the morning or preprandial for healthy volunteers)</time_frame>
    <description>OSI in mmol trolox/L.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Oxidative Stress</condition>
  <condition>Low Grade Squamous Intraepithelial Lesion</condition>
  <condition>High-Grade Squamous Intraepithelial Lesions</condition>
  <arm_group>
    <arm_group_label>low grade squamous intraepithelial lesion(LGSIL)</arm_group_label>
    <description>low grade squamous intraepithelial lesion(LGSIL) n=100</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high grade squamous intraepithelial lesion(HGSIL)</arm_group_label>
    <description>high grade squamous intraepithelial lesion(HGSIL) n=100</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>Healthy volunteers n=100</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Disulphide(μmol/L)</intervention_name>
    <description>Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with sphectrophotometry</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>high grade squamous intraepithelial lesion(HGSIL)</arm_group_label>
    <arm_group_label>low grade squamous intraepithelial lesion(LGSIL)</arm_group_label>
    <other_name>Native thiol (μmol/L)</other_name>
    <other_name>Total thiol (μmol/L)</other_name>
    <other_name>Nativethiol/totalthiol(%)</other_name>
    <other_name>Disulfide/nativethiol(%)</other_name>
    <other_name>Disulfide/totalthiol(%)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Total Oxidant Capacity(μmolH2O2Equiv/L)</intervention_name>
    <description>Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with sphectrophotometry</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>high grade squamous intraepithelial lesion(HGSIL)</arm_group_label>
    <arm_group_label>low grade squamous intraepithelial lesion(LGSIL)</arm_group_label>
    <other_name>Total Antioxidant Capacity(mmolTroloxEquiv/L)</other_name>
    <other_name>Oxidative stress Index (Arbitrary Unite)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The diagnosis of preinvasive cervical lesions was made histopathologically by cervical
        biopsy. An experienced pathologist performed histopathologic examinations
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • Histopathologically confirmed diagnosis of LGSIL or HGSIL

        Exclusion Criteria:

          -  pulmonary disease

          -  pulmonary hypertension

          -  cardiac dysfunction

          -  renal dysfunction

          -  liver disease

          -  chronic ishemia

          -  systemic inflammation

          -  other cervical biopy results than LGSIL or HGSIL

          -  concomitant malignancy

          -  patients who use vitamin A,C or E (antioxidant vitamins)

          -  patients who use smoke • patients who use drink alcohol

          -  patients who use addictive for any drug
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>histopathologically confirmed LGSIL or HGSIL</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mugla Sıtkı Kocman University Faculty of Medicine</name>
      <address>
        <city>Mugla</city>
        <zip>48000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 24, 2019</study_first_submitted>
  <study_first_submitted_qc>November 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2019</study_first_posted>
  <last_update_submitted>February 4, 2020</last_update_submitted>
  <last_update_submitted_qc>February 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Muğla Sıtkı Koçman University</investigator_affiliation>
    <investigator_full_name>Burak Sezgin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>thiol disulfide balance</keyword>
  <keyword>preinvasive lesion</keyword>
  <keyword>cervix</keyword>
  <keyword>oxidative stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Squamous Intraepithelial Lesions of the Cervix</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

